|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ren JS, Masuyer E and Ferlay J:
Global estimates of cancer prevalence for 27 sites in the adult
population in 2008. Int J Cancer. 132:1133–1145. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ibrahim AS, Khaled HM, Mikhail NN, Baraka
H and Kamel H: Cancer incidence in egypt: Results of the national
population-based cancer registry program. J Cancer Epidemiol.
2014:4379712014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Newell B, Proust K, Dyball R and McManus
P: Seeing obesity as a systems problem. N S W Public Health Bull.
18:214–218. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kaur T and Zhang ZF: Obesity, breast
cancer and the role of adipocytokines. Asian Pac J Cancer Prev.
6:547–552. 2005.PubMed/NCBI
|
|
6
|
Popkin BM: Understanding global nutrition
dynamics as a step towards controlling cancer incidence. Nat Rev
Cancer. 7:61–67. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Reeves GK, Pirie K, Beral V, Green J,
Spencer E and Bull D; Million Women Study Collaboration, : Cancer
incidence and mortality in relation to body mass index in the
Million Women Study: Cohort study. BMJ. 335:11342007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Danaei G, Hoorn S Vander, Lopez AD, Murray
CJ and Ezzati M; Comparative Risk Assessment collaborating group
(Cancers), : Causes of cancer in the world: Comparative risk
assessment of nine behavioural and environmental risk factors.
Lancet. 366:1784–1793. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Frühbeck G, Gómez-Ambrosi J, Muruzábal FJ
and Burrell MA: The adipocyte: A model for integration of endocrine
and metabolic signaling in energy metabolism regulation. Am J
Physiol Endocrinol Metab. 280:E827–E847. 2001.PubMed/NCBI
|
|
10
|
Porter GA, Inglis KM, Wood LA and
Veugelers PJ: Effect of obesity on presentation of breast cancer.
Ann Surg Oncol. 13:327–332. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huber KE, Carey LA and Wazer DE: Breast
cancer molecular subtypes in patients with locally advanced
disease: Impact on prognosis, patterns of recurrence, and response
to therapy. Semin Radiat Oncol. 19:204–210. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Diamond T, Vine J, Smart R and Butler P:
Thyrotoxic bone disease in women: A potentially reversible
disorder. Ann Intern Med. 120:8–11. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang Y, Proenca R, Maffei M, Barone M,
Leopold L and Friedman JM: Positional cloning of the mouse obese
gene and its human homologue. Nature. 372:425–432. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tartaglia LA: The leptin receptor. J Biol
Chem. 272:6093–6096. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Halaas JL, Gajiwala KS, Maffei M, Cohen
SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK and Friedman JM:
Weight-reducing effects of the plasma protein encoded by the obese
gene. Science. 269:543–546. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bray GA: The underlying basis for obesity:
Relationship to cancer. J Nutr. 132(11 Suppl): S3451–S3455.
2002.
|
|
17
|
Andò S and Catalano S: The multifactorial
role of leptin in driving the breast cancer microenvironment. Nat
Rev Endocrinol. 8:263–275. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ahima RS and Flier JS: Adipose tissue as
an endocrine organ. Trends Endocrinol Metab. 11:327–332. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bonnet M, Delavaud C, Laud K, Gourdou I,
Leroux C, Djiane J and Chilliard Y: Mammary leptin synthesis, milk
leptin and their putative physiological roles. Reprod Nutr Dev.
42:399–413. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Snoussi K, Strosberg AD, Bouaouina N, Ben
Ahmed S, Helal AN and Chouchane L: Leptin and leptin receptor
polymorphisms are associated with increased risk and poor prognosis
of breast carcinoma. BMC Cancer. 6:382006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Garofalo C and Surmacz E: Leptin and
cancer. J Cell Physiol. 207:12–22. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Purohit A, Newman SP and Reed MJ: The role
of cytokines in regulating estrogen synthesis: Implications for the
etiology of breast cancer. Breast Cancer Res. 4:65–69. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vona-Davis L and Rose DP: Adipokines as
endocrine, paracrine, and autocrine factors in breast cancer risk
and progression. Endocr Relat Cancer. 14:189–206. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mauro L, Catalano S, Bossi G, Pellegrino
M, Barone I, Morales S, Giordano C, Bartella V, Casaburi I and Andò
S: Evidences that leptin Up-regulates E-cadherin expression in
breast cancer: Effects on tumor growth and progression. Cancer Res.
67:3412–3421. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Park HY, Kwon HM, Lim HJ, Hong BK, Lee JY,
Park BE, Jang Y, Cho SY and Kim HS: Potential role of leptin in
angiogenesis: Leptin induces endothelial cell proliferation and
expression of matrix metalloproteinases in vivo and in vitro. Exp
Mol Med. 33:95–102. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Frankenberry KA, Skinner H, Somasundar P,
McFadden DW and Vona-Davis LC: Leptin receptor expression and cell
signaling in breast cancer. Int J Oncol. 28:985–993.
2006.PubMed/NCBI
|
|
27
|
Gonzalez RR, Cherfils S, Escobar M, Yoo
JH, Carino C, Styer AK, Sullivan BT, Sakamoto H, Olawaiye A,
Serikawa T, et al: Leptin signaling promotes the growth of mammary
tumors and increases the expression of vascular endothelial growth
factor (VEGF) and its receptor type two (VEGF-R2). J Biol Chem.
281:26320–26328. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gonzalez R Rene, Watters A, Xu Y, Singh
UP, Mann DR, Rueda BR and Penichet ML: Leptin-signaling inhibition
results in efficient anti-tumor activity in estrogen receptor
positive or negative breast cancer. Breast Cancer Res. 11:R362009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Perera CN, Chin HG, Duru N and Camarillo
IG: Leptin-regulated gene expression in MCF-7 breast cancer cells:
Mechanistic insights into leptin-regulated mammary tumor growth and
progression. J Endocrinol. 199:221–233. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
El-Shinawi M, Abdelwahab SF, Sobhy M, Nouh
MA, Sloane BF and Mohamed MM: Capturing and characterizing immune
cells from breast tumor microenvironment: An innovative surgical
approach. Ann Surg Oncol. 17:2677–2684. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hwang CS, Loftus TM, Mandrup S and Lane
MD: Adipocyte differentiation and leptin expression. Annu Rev Cell
Dev Biol. 13:231–259. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Garofalo C, Koda M, Cascio S, Sulkowska M,
Kanczuga-Koda L, Golaszewska J, Russo A, Sulkowski S and Surmacz E:
Increased expression of leptin and the leptin receptor as a marker
of breast cancer progression: Possible role of obesity-related
stimuli. Clin Cancer Res. 12:1447–1453. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nyante SJ, Gammon MD, Kaufman JS, Bensen
JT, Lin DY, Barnholtz-Sloan JS, Hu Y, He Q, Luo J and Millikan RC:
Common genetic variation in adiponectin, leptin, and leptin
receptor and association with breast cancer subtypes. Breast Cancer
Res Treat. 129:593–606. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jeong YJ, Bong JG, Park SH, Choi JH and Oh
HK: Expression of leptin, leptin receptor, adiponectin, and
adiponectin receptor in ductal carcinoma in situ and invasive
breast cancer. J Breast Cancer. 14:96–103. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Stattin P, Söderberg S, Biessy C, Lenner
P, Hallmans G, Kaaks R and Olsson T: Plasma leptin and breast
cancer risk: A prospective study in northern Sweden. Breast Cancer
Res Treat. 86:191–196. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Miyoshi Y, Funahashi T, Tanaka S, Taguchi
T, Tamaki Y, Shimomura I and Noguchi S: High expression of leptin
receptor mRNA in breast cancer tissue predicts poor prognosis for
patients with high, but not low, serum leptin levels. Int J Cancer.
118:1414–1419. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Harris HR, Tworoger SS, Hankinson SE,
Rosner BA and Michels KB: Plasma leptin levels and risk of breast
cancer in premenopausal women. Cancer Prev Res (Phila).
4:1449–1456. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Whiteman MK, Hillis SD, Curtis KM,
McDonald JA, Wingo PA and Marchbanks PA: Body mass and mortality
after breast cancer diagnosis. Cancer Epidemiol Biomarkers Prev.
14:2009–2014. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Grossmann ME, Ray A, Nkhata KJ, Malakhov
DA, Rogozina OP, Dogan S and Cleary MP: Obesity and breast cancer:
Status of leptin and adiponectin in pathological processes. Cancer
Metastasis Rev. 29:641–653. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Razmkhah M, Jaberipour M, Hosseini A,
Safaei A, Khalatbari B and Ghaderi A: Expression profile of IL-8
and growth factors in breast cancer cells and adipose-derived stem
cells (ASCs) isolated from breast carcinoma. Cell Immunol.
265:80–85. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lim S, Honek J, Xue Y, Seki T, Cao Z,
Andersson P, Yang X, Hosaka K and Cao Y: Cold-induced activation of
brown adipose tissue and adipose angiogenesis in mice. Nat Protoc.
7:606–615. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Arita Y, Kihara S, Ouchi N, Takahashi M,
Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K,
et al: Paradoxical decrease of an adipose-specific protein,
adiponectin, in obesity. Biochem Biophys Res Commun. 257:79–83.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tessitore L, Vizio B, Jenkins O, de
Stefano I, Ritossa C, Argiles JM, Benedetto C and Mussa A: Leptin
expression in colorectal and breast cancer patients. Int J Mol Med.
5:421–426. 2000.PubMed/NCBI
|
|
45
|
Ostlund RE Jr..Yang JW, Klein S and
Gingerich R: Relation between plasma leptin concentration and body
fat, gender, diet, age, and metabolic covariates. J Clin Endocrinol
Metab. 81:3909–3913. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hou WK, Xu YX, Yu T, Zhang L, Zhang WW, Fu
CL, Sun Y, Wu Q and Chen L: Adipocytokines and breast cancer risk.
Chin Med J (Engl). 120:1592–1596. 2007.PubMed/NCBI
|
|
47
|
Al Awadhi SA, Al Khaldi RM, Al Rammah T,
Kapila K and Mojiminiyi OA: Associations of adipokines &
insulin resistance with sex steroids in patients with breast
cancer. Indian J Med Res. 135:500–505. 2012.PubMed/NCBI
|
|
48
|
Mohammadzadeh G, Ghaffari MA, Bafandeh A
and Hosseini SM: Association of serum soluble leptin receptor and
leptin levels with breast cancer. J Res Med Sci. 19:433–438.
2014.PubMed/NCBI
|
|
49
|
Lorincz AM and Sukumar S: Molecular links
between obesity and breast cancer. Endocr Relat Cancer. 13:279–292.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Strong AL, Ohlstein JF, Biagas BA, Rhodes
LV, Pei DT, Tucker HA, Llamas C, Bowles AC, Dutreil MF, Zhang S, et
al: Leptin produced by obese adipose stromal/stem cells enhances
proliferation and metastasis of estrogen receptor positive breast
cancers. Breast Cancer Res. 17:1122015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhang Y, Daquinag A, Traktuev DO,
Amaya-Manzanares F, Simmons PJ, March KL, Pasqualini R, Arap W and
Kolonin MG: White adipose tissue cells are recruited by
experimental tumors and promote cancer progression in mouse models.
Cancer Res. 69:5259–5266. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Leek RD: The prognostic role of
angiogenesis in breast cancer. Anticancer Res. 21:4325–4331.
2001.PubMed/NCBI
|
|
53
|
Somiari SB, Shriver CD, Heckman C, Olsen
C, Hu H, Jordan R, Arciero C, Russell S, Garguilo G, Hooke J and
Somiari RI: Plasma concentration and activity of matrix
metalloproteinase 2 and 9 in patients with breast disease, breast
cancer and at risk of developing breast cancer. Cancer Lett.
233:98–107. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Linderholm BK, Hellborg H, Johansson U,
Elmberger G, Skoog L, Lehtiö J and Lewensohn R: Significantly
higher levels of vascular endothelial growth factor (VEGF) and
shorter survival times for patients with primary operable
triple-negative breast cancer. Ann Oncol. 20:1639–1646. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Strong AL, Strong TA, Rhodes LV, Semon JA,
Zhang X, Shi Z, Zhang S, Gimble JM, Burow ME and Bunnell BA:
Obesity associated alterations in the biology of adipose stem cells
mediate enhanced tumorigenesis by estrogen dependent pathways.
Breast Cancer Res. 15:R1022013. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Nieman KM, Romero IL, Van Houten B and
Lengyel E: Adipose tissue and adipocytes support tumorigenesis and
metastasis. Biochim Biophys Acta. 1831:1533–1541. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Weisberg SP, McCann D, Desai M, Rosenbaum
M, Leibel RL and Ferrante AW Jr.: Obesity is associated with
macrophage accumulation in adipose tissue. J Clin Invest.
112:1796–1808. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Gnerlich JL, Yao KA, Fitchev PS,
Goldschmidt RA, Bond MC, Cornwell M and Crawford SE: Peritumoral
expression of adipokines and fatty acids in breast cancer. Ann Surg
Oncol. 20 Suppl 3:S731–S738. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Dehdashti F, Mortimer JE, Trinkaus K,
Naughton MJ, Ellis M, Katzenellenbogen JA, Welch MJ and Siegel BA:
PET-based estradiol challenge as a predictive biomarker of response
to endocrine therapy in women with estrogen-receptor-positive
breast cancer. Breast Cancer Res Treat. 113:509–517. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Calle EE, Rodriguez C, Walker-Thurmond K
and Thun MJ: Overweight, obesity, and mortality from cancer in a
prospectively studied cohort of U.S. adults. N Engl J Med.
348:1625–1638. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Catalano S, Marsico S, Giordano C, Mauro
L, Rizza P, Panno ML and Andò S: Leptin enhances, via AP-1,
expression of aromatase in the MCF-7 cell line. J Biol Chem.
278:28668–28676. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Garofalo C, Sisci D and Surmacz E: Leptin
interferes with the effects of the antiestrogen ICI 182,780 in
MCF-7 breast cancer cells. Clin Cancer Res. 10:6466–6475. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Dubois V, Jardé T, Delort L, Billard H,
Bernard-Gallon D, Berger E, Geloen A, Vasson MP and Caldefie-Chezet
F: Leptin induces a proliferative response in breast cancer cells
but not in normal breast cells. Nutr Cancer. 66:645–655. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Khanal T, Kim HG, Do MT, Choi JH, Won SS,
Kang W, Chung YC, Jeong TC and Jeong HG: Leptin induces CYP1B1
expression in MCF-7 cells through ligand-independent activation of
the ERα pathway. Toxicol Appl Pharmacol. 277:39–48. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Alshaker H, Krell J, Frampton AE, Waxman
J, Blyuss O, Zaikin A, Winkler M, Stebbing J, Yagüe E and
Pchejetski D: Leptin induces upregulation of sphingosine kinase 1
in oestrogen receptor-negative breast cancer via Src family
kinase-mediated, janus kinase 2-independent pathway. Breast Cancer
Res. 16:4262014. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Qian Y, Shi D, Qiu J, Zhu F, Qian J, He S,
Shu Y, Yin Y and Chen X: ObRb downregulation increases breast
cancer cell sensitivity to tamoxifen. Tumour Biol. 36:6813–6821.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Wang L, Tang C, Cao H, Li K, Pang X, Zhong
L, Dang W, Tang H, Huang Y, Wei L, et al: Activation of IL-8 via
PI3K/Akt-dependent pathway is involved in leptin-mediated
epithelial-mesenchymal transition in human breast cancer cells.
Cancer Biol Ther. 16:1220–1230. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Takeda K, Noguchi K, Shi W, Tanaka T,
Matsumoto M, Yoshida N, Kishimoto T and Akira S: Targeted
disruption of the mouse Stat3 gene leads to early embryonic
lethality. Proc Natl Acad Sci USA. 94:3801–3804. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Bromberg JF, Wrzeszczynska MH, Devgan G,
Zhao Y, Pestell RG, Albanese C and Darnell JE Jr.: Stat3 as an
oncogene. Cell. 98:295–303. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Giordano C, Chemi F, Panza S, Barone I,
Bonofiglio D, Lanzino M, Cordella A, Campana A, Hashim A, Rizza P,
et al: Leptin as a mediator of tumor-stromal interactions promotes
breast cancer stem cell activity. Oncotarget. 7:1262–1275.
2015.
|
